Some notable highlights of Qmed Asia to date:

• Achieved c. RM12mil revenue in 2022, whilst being profitable
• Served more than 2 million patients nationwide, managing more than 11 million of bookings
• Official partner in providing both Clinical & Digital Solutions for 42 COVID-19 vaccination centers (PPV) during the pandemic
• Winning the trust of prominent clients and signing partnerships with the likes of Nestlé Malaysia, SP Setia Group, Qualitas Medical Group and Lippo Life Indonesia
• Incorporated in MySejahtera App in providing appointment booking & online queue solution to nearby clinics for all users
• Recipient of multiple awards as recognition for our innovation capability by both local and international organizations

Qmed Asia has expanded its offerings from assisting healthcare providers with managing patient journey, to also expanding their value offerings through tele-consultation with remote patient monitoring and tele-radiology. Qmed Asia will be implementing its digital health solution into Indonesia market next, at same time also in discussion with other regional market stakeholders in the Philippines and Vietnam, and in preparation to roll-out more value-based digital health solutions for healthcare providers, patients and corporates.

Qmed Asia is recognized and supported by both the state and private healthcare authorities to launch its dedicated digital health solutions for the users. Being the recipient of several awards, Qmed Asia has been well recognized for its innovation capability by both local and international organizations.

Join Us on Our Healthcare Digitalization Journey

Today, we'd like to invite you to join us, be our shareholder in the journey of digitalization in healthcare and Qmed Asia’s IPO journey via Equity Crowdfunding on Leet Capital.

We are offering early bird rewards worth up to RM 8,000, together with bonus shares incentives. To find out more about Qmed Asia and the available incentive structure click here: https://leet.capital/company/Qmed-Asia 

We are also conducting physical roadshows where we will be showcasing our offerings and sharing with you personally everything about Qmed Asia.

RSVP for the physical exclusive roadshow here: Qmed Asia Investor Roadshow - Leet Capital

Opportunity to Invest

If you are still reading at this point, thanks a lot!

To summarize at the opportunity that you are looking at, to join our journey of digitalization in healthcare and Qmed Asia’s IPO journey via Equity Crowdfunding on Leet Capital:

• Qmed Asia is founded by a group of doctors, who understand the healthcare industry well enough and at the same time having a group of seasoned engineering team in-house to build the proprietary solutions that is specifically crafted for local market.
• Qmed Asia is currently on its growth journey to becoming a household name in Malaysia healthcare industry. We are the All-In-One Healthcare Companion for both the Healthcare Providers and Patients, where we offer a broad range of digital health solutions to cater for different stakeholders.
• Qmed Asia is recognized and supported by both the state and private healthcare authorities to launch its dedicated digital health solutions for the users. Being the recipient of several awards, Qmed Asia has been well recognized for its innovation capability by both local and international organizations.
• Qmed Asia has been in the market for 4 years and have onboarded over 4,000 healthcare providers and 2 million of clients or patients. This year Qmed Asia will be implementing its digital health solution into Indonesia market along with the local partner, at the same time in discussion with Vietnam and Philippines market stakeholders.
• Qmed Asia is currently at its early phase of capital funding round with modest valuation, and healthcare segment will continue to be a high-growth market during the next decade.